I'm asking seriously. A drug called rapamycin is in clinical trials. It could slow the decline of the immune system—effectively, delaying aging. You'd live longer, but you'd also have more time to develop dementia or other problems. So would you take it?
Joan Mannick co-founded the company testing the drug. She'll be speaking at EmTech MIT this September. Come listen, and then debate the ethics of prolonging aging with hundreds of your peers.
Here's another one. We could force companies like Facebook to police hate speech and abuse. Should we? Do you really want Facebook to decide what you can say? On the other hand, do you want trolls and extremists having free rein?
Alex Stamos was Facebook's chief security officer. Wrestling with these questions was his day job. Now he's at Stanford, trying to build a system for holding tech companies accountable. He'll be speaking at EmTech MIT this September. Come listen, and then discuss what freedom of speech means in the 21st century with some of the brightest minds in tech.
EmTech MIT is our annual emerging technologies conference, and it's three days of non-stop brain food on some of the biggest and thorniest questions facing humanity. Here are some of the other topics we've got lined up:
Cutting-edge advances and ethical dilemmas in personalized medicine
Living in a world of ubiquitous facerecognition
Preparing for increasingly severe climate change
Why the nature of work is changing and how you can navigate it
How AI could reinvent whole industries where innovation has stalled
How quantum technology could usher in a new era of computing
What the fast-growing space industry means for life here on Earth
How we can use tech to do more good in the world
Come join us in Cambridge, Massachusetts, at the famed MIT Media Lab, on September 17-19. You'll leave with your head buzzing and a host of new ideas on how technology will affect the world you live, work, and play in.
You can sign up here. Now that you know what we'll be talking about, can you afford not to come?
The mission of MIT Technology Review is to bring about better-informed and more conscious decisions about technology through authoritative, influential, and trustworthy journalism.
Click here to manage your newsletter preferences and email settings.
MIT Technology Review, One Main Street, Cambridge, MA 02142
To unsubscribe from all emails, including newsletters, follow this link.
